Skip to main content
Equibles
CERT logo

CERT · Certara, Inc. · Metrics

Track CERT — free

Use CERT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CERT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$10.33 +0.24 (+2.38%) At close · Oct 23
S&P 600 member Russell 2000 member Rebalance outlook locked
Customer concentration — top 10 customers 24% of revenue

10 customers — 24% of revenue (the year ended December 31, 2025)

“Our ten largest customers accounted for 24% of revenues for the year ended December 31, 2025.”
View the 10-K filed Feb 26, 2026
Market Cap
$1.58B
Shares
152.54M
Volume · Oct 23 2.06M Avg daily vol (3M) 3M

CERT metrics

93 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$10.33
Market cap
$1.58B

Price action

20 metrics
Price change (1W)
+10.2%
Price change (30D)
+13.4%
Price change (3M)
+37.5%
Price change (6M)
+63.4%
Price change (YTD)
+17.3%
Price change (1Y)
-17.4%
Trailing year
Price change (5Y)
-72.9%
52-week high
$12.66
52-week low
$4.48
Change from 52-week high
-18.4%
Change from 52-week low
+130.6%
Annualized volatility
59.5%
Annualized volatility (3M)
49.9%
Beta
0.7
RSI (14D)
65.3
Price vs SMA 50
+18.3%
Price vs SMA 200
+43.0%
Avg volume (3M)
3.00M
Relative volume
0.7
Average dollar volume
$25.43M

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
152.54M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
4.0×
reciprocal yield 25.0%
EV / EBITDA
21.7×
reciprocal yield 4.6%
EV / EBIT
1,376.5×
reciprocal yield 0.1%
P / sales
3.7×
reciprocal yield 26.7%
P / book
1.6
reciprocal yield 61.3%
FCF yield
—
TTM · current market cap
Buyback yield
4.8%
P / FCF
—
P / operating cash flow
19.0
reciprocal yield 5.3%
Earnings yield
-4.3%

Historical valuation

8 metrics
P / E historical average (3Y)
193.2×
reciprocal yield 0.5%
P / E historical average (5Y)
193.2×
reciprocal yield 0.5%
EV / revenue historical average (3Y)
5.3×
reciprocal yield 18.7%
EV / revenue historical average (5Y)
7.0×
reciprocal yield 14.4%
EV / EBIT historical average (3Y)
247.4×
reciprocal yield 0.4%
EV / EBIT historical average (5Y)
217.6×
reciprocal yield 0.5%
EV / EBITDA historical average (3Y)
1,057.0×
reciprocal yield 0.1%
EV / EBITDA historical average (5Y)
673.8×
reciprocal yield 0.1%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
4.8%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
—
Operating margin
0.3%
Trailing 12 months
Net margin
-16.3%
Gross profit (TTM)
$213.31M
Operating profit (TTM)
$1.22M
Net income (TTM)
−$68.40M
Trailing 12 months
Diluted EPS (TTM)
$-0.45
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$2.67
Gross profit per diluted share (TTM)
$1.34
Operating profit per diluted share (TTM)
$0.01
EBITDA per diluted share (TTM)
$0.49
Net income per diluted share (TTM)
$-0.44
Operating cash flow per diluted share (TTM)
$0.52
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$0.28
Stock compensation per diluted share (TTM)
—
Book value per share
$6.68

Growth

11 metrics
Revenue growth YoY
+1.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$420.66M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-4.6%
Year over year · fewer shares
Revenue CAGR (3Y)
+7.7%
Revenue CAGR (5Y)
+11.5%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+1.2%
FCF CAGR (5Y)
+16.6%

Quality

14 metrics
Return on equity
-7.1%
Return on assets
-4.9%
Debt / equity
0.3
Current ratio
2.6
EBITDA (TTM)
$77.52M
Free cash flow (TTM)
—
Quick ratio
2.6
Interest coverage
0.1
Net debt / EBITDA
1.4
Return on invested capital
—
Trailing 12 months
Net cash
−$107.70M
Latest balance sheet
Cash & equivalents
$184.14M
Total assets
$1.40B
Total debt
$291.84M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$82.86M
Capital expenditures (TTM)
$2.48M
R&D (TTM)
$43.54M
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
10.3%
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
242
13F filer change QoQ
-15
Institutional ownership
88.3%
Conviction holders (share of 13F filers)
1.7%
Crowding (high-turnover and private-fund holders)
37.7%
Private-fund adviser ownership
32.3%
Active holders' share change QoQ
-14.5%
Holder tenure
9.9
Price vs estimated holder cost
-36.5%

Ownership (registered funds)

1 metrics
Index-fund ownership
22.2%

Short interest

3 metrics
Short interest
18.2%
Latest settlement · 9.0 days to cover
Days to cover
9.0d
Short-squeeze score
71 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1827090 CUSIP 15687V109 13F (30d) 33 filings 33 filers Visit website Investor relations